Vancouver, Canada

Ralph E Durand


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ralph E Durand: Innovator in Cancer Therapy

Introduction

Ralph E Durand is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of cancer therapy through his innovative approaches. His work primarily focuses on enhancing the efficiency of transforming cancer cells using nucleic acids.

Latest Patents

Ralph E Durand holds a patent for a method titled "Combination therapy using nucleic acids and radio therapy." This invention relates to methods for increasing the efficiency of transformation of cycling cells. The methods involve synchronizing cells at a first stage of the cell cycle and transforming the cells at a second stage with a genetically engineered nucleic acid that encodes a desired gene product. The invention aims to improve cancer therapy by efficiently transforming cancer cells with nucleic acids that encode gene products inhibiting the growth of cancer cells.

Career Highlights

Throughout his career, Ralph E Durand has worked with prominent organizations such as Inex Pharmaceuticals Corporation and the British Columbia Cancer Agency. His experience in these institutions has allowed him to develop and refine his innovative methods in cancer treatment.

Collaborations

Ralph E Durand has collaborated with notable professionals in his field, including Phalgun Joshi and Roger W Graham. These collaborations have contributed to the advancement of his research and the development of effective cancer therapies.

Conclusion

Ralph E Durand's work in cancer therapy exemplifies the impact of innovative thinking in medical science. His patent and career achievements highlight his commitment to improving treatment options for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…